K. Abulikemu

Safety and Efficacy of Nemolizumab for Atopic Dermatitis With Pruritus: A Systematic Review and Meta-Regression Analysis of Randomized Controlled Trials

Junqin Liang, X. Kang, F. Hu, 2022, Frontiers in Immunology.

Targeting therapy in pemphigus: Where are we now and where are we going?

Junqin Liang, X. Kang, F. Hu, 2023, Heliyon.

Nine cases of refractory bullous pemphigoid treated with dupilumab and literature review.

Junqin Liang, X. Kang, Y. Qiu, 2023, International immunopharmacology.

Interleukin‐37 inhibits desmoglein‐3 endocytosis and keratinocyte dissociation via upregulation of Caveolin‐1 and inhibition of the STAT3 pathway

Y. Qiu, Junqin Liang, X. Kang, 2023, Journal of the European Academy of Dermatology and Venereology.